RAinfo.org

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA is announcing steps it is taking to further modernize its approach to evaluating and supporting the development of innovative animal and veterinary products, to increase regulatory flexibility, predictability and efficiency.

FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law.

FDA approved and authorized for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

La FDA está emitiendo cartas de advertencia a tres fabricantes de fórmula infantil como parte del compromiso continuo de la agencia de mejorar la supervisión normativa para ayudar a garantizar que la industria esté produciendo fórmula infantil en las condiciones más inocuas posibles.

The FDA is issuing warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the safest conditions possible.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA has approved the first biosimilar to Tysabri (natalizumab) injection for the treatment of relapsing forms of multiple sclerosis.

The FDA has selected James “Jim” Jones to serve as the first Deputy Commissioner for Human Foods. Jones will lead the charge in setting and advancing priorities for a proposed unified Human Foods Program. Jones is scheduled to begin at the FDA on Sept. 24.

FDA approves Abrysvo for immunization at 32 through 36 weeks gestational age of pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA issued a draft guidance which, once finalized, will assist individuals submitting cosmetic product facility registrations and product listings, including ingredients, to the FDA.